BridgeMD
Compares treatment options for Advanced Cancer, Various, NOS
Official title Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)
ClinicalTrials.gov ID: NCT07312760
What this study is testing
- What it's testing
- The psychological challenges faced by patients with incurable cancer and their caregivers include an uncertain future, fear of dying and uncontrollable suffering, grief, and loneliness. In a significant subgroup, this challenge is associated with significant fear and existential distress.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- UICC stage III/IV solid tumor or advanced hematological cancer
- Physical condition at beginning of treatment sufficient for outpatient treatment
- Existential distress due to at least one of the following concerns: loss of hope, demoralization, fear of the future, loneliness, death anxiety...
- Severity of distress: significant subjective distress and impairment in functioning
You likely can't join if
- Acute suicidality with concrete or impending intent to follow through (suicide plan)
- diagnosis of a substance dependence, substance abuse, or psychotic disorder (exception: tobacco-related disorders)
- Inability to adhere to a psychotherapeutic setting
- Other current psychotherapeutic or psycho-oncological treatment according to TAU definition
- Insufficient German to give informed consent and complete self-report questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Düsseldorf, Germany
- Hamburg, Germany
- Würzburg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Düsseldorf, Germany; Hamburg, Germany; Würzburg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.